Conference Roundup: 2023 Annual Research Meeting
A curated list of appearances featuring CHERISH researchers.
June 24-27, 2023
2023 Academy Health Annual Research Meeting, Seattle, WA
![main-post-image-ARM23](https://cherishresearch.org/wp-content/uploads/2023/06/main-post-image-ARM23-800x600.jpg)
Connect with CHERISH investigators, CHERISH Research Affiliates, Advisory Board members, and pilot grant recipients in person as they present their research at #ARM23.
Friday, June 23, 2023
- Margaret Kuklinski, PhD, MA, University of Washington School of Social Work
- Driving Tomorrow’s Outcomes Through Clinical Research in Real-World Settings: Essentials of Embedded Pragmatic Clinical Trials Workshop, 8:00 AM – 5:00 PM at 2AB (Level 2, Seattle Convention Center), Speakers
Saturday, June 24, 2023
- Susan Busch, PhD, Yale School of Public Health
- The Future of Mental Health and Substance Use Treatment Services in the United States, 12:30 PM – 2:00 PM PDT at 613-614 (Level 6, Seattle Convention Center), Panelist
- Margaret Kuklinski, PhD, MA, University of Washington School of Social Work
- Driving Tomorrow’s Outcomes Through Clinical Research in Real-World Settings: Essentials of Embedded Pragmatic Clinical Trials Workshop, 8:00 AM – 12:00 PM at 2AB (Level 2, Seattle Convention Center), Speakers
- Jonathan Purtle, DrPH, MPH, MSc New York University School of Global Public Health
- The Future of Mental Health and Substance Use Treatment Services in the United States, 12:30 PM – 2:00 PM PDT at 613-614 (Level 6, Seattle Convention Center), Moderator
Sunday, June 25, 2023
- Susan Busch, PhD, Yale School of Public Health
- Digital Health Technologies for Opioid Use Disorder in Accountable Care Organizations: Results from a National Survey, 3:30 PM – 4:45 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Dhruv Khurana, PhD, MS, MA, David Geffen School of Medicine at UCLA
- Intervening on Community Conditions and Structural Drivers of Health to Realize Individual and Collective Benefits, 5:00 PM – 6:30 PM PDT at 4C-2 (Level 4, Seattle Convention Center), Chair
- Margaret Lowenstein, MD, MSHP, Co-director, Dissemination & Policy Core, University of Pennsylvania
- Mobile Service Delivery in Response to the Opioid and HIV Epidemics in Philadelphia, 3:30 PM – 4:45 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Catherine Maclean, PhD, George Mason University
- Effects of Eliminating Behavioral Health Cost-Sharing on Prescription Drug Use, 11:00 AM – 12:30 PM at 4C-3 (Level 4, Seattle Convention Center), Author
- Implementation of the New Mexico “No Behavioral Health Cost Sharing Law:” Perceptions of Key Informants, 11:00 AM – 12:30 PM at 4C-3 (Level 4, Seattle Convention Center), Author
- Harold Pollack, PhD, MPP, University of Chicago School of Social Service Administration
- The Association of Patient Age and Employment with Treatment Outcomes Among Criminal-Legal-System-Referred Patients in Outpatient Opioid Use Disorder Treatment, 8:00 AM – 9:30 AM at 4C-4 (Level 4, Seattle Convention Center), Author
- ABLE Accounts for People with Disabilities: Disparities By Income and Disability-Type, 11:00 AM – 12:30 PM at 618 (Level 6, Seattle Convention Center), Presenting Author
- Daniel Polsky, PhD, Bloomberg Distinguished Professor at the Bloomberg, School of Public Health and the Carey School of Business, Johns Hopkins University
- Network Breadth for Psychiatrists in Medicare Advantage Is Substantially Narrower Than in Medicaid and ACA Markets, 11:00 AM – 12:30 PM at 4C-3 (Level 4, Seattle Convention Center), Author
- Jonathan Purtle, DrPH, MPH, MSc New York University School of Global Public Health
- State-Level Increases in Call Volume to the 988 Suicide and Crisis Lifeline, Associated Cost Estimates, and Earmarked Funding Following the Implementation of 9-8-8, 1:45 PM – 3:15 PM at 618 (Level 6, Seattle Convention Center), Presenting Author
- Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health
- Effects of Eliminating Behavioral Health Cost-Sharing on Prescription Drug Use, 11:00 AM – 12:30 PM at 4C-3 (Level 4, Seattle Convention Center), Author
- Implementation of the New Mexico “No Behavioral Health Cost Sharing Law:” Perceptions of Key Informants, 11:00 AM – 12:30 PM at 4C-3 (Level 4, Seattle Convention Center), Author
- Theresa Shireman, PhD, MS, Brown University School of Public Health
- Impact of Acute Myocardial Infarction on Statin Adherence Among Medicaid Beneficiaries in 14 States from 2001 to 2015, 3:30 PM – 4:45 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Cindy Parks Thomas, PhD, Brandeis University Heller School for Social Policy and Management
- Quality of Opioid Use Disorder Treatment for Persons Covered By Medicaid with and without Disabling Conditions, 8:00 AM – 9:30 AM at 4C-4 (Level 4, Seattle Convention Center), Presenting Author
- Benjamin Ukert, PhD, Texas A & M University School of Public Health
- Impact of Telemedicine Licensure Waivers on Interstate Delivery of Telemedicine and Access to Care, 3:30 PM – 4:45 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Todd Wagner, PhD, Stanford University and VA Health, Economics Resource Center
- Declining Attrition from VA Among New Women Veteran Primary Care Patients, 3:30 PM – 4:45 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
Monday, June 26, 2023
- Marcus Bachhuber, MD, MSHP, LSU Health Sciences Center
- Health Services Use Among Formerly Incarcerated Louisiana Medicaid Members within One Year of Release, 1:00 PM – 2:30 PM at 612 (Level 6, Seattle Convention Center), Author
- Brittany Bass, PhD, UCLA Integrated Substance Abuse Programs
- The Effect of the Drug Medi-Cal Organized Delivery System on Substance Use Disorder Treatment Access: Evidence from California, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Yuhua Bao, PhD, Investigator, Population Data & Modeling Core, Investigator, Administrative Core, Weill Cornell Medicine
- Association between Diagnosis Setting and Treatment Initiation Among Medicare Patients with Hepatitis C, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Out-of-Pocket Costs and Initiation of HCV Treatment Among Medicare Beneficiaries Receiving Low-Income Subsidy, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Czarina Behrends, PhD, MPH, Weill Cornell Medicine
- “a Lot of Us ‘essential’ Workers Could Replace the Word with ‘expendable'”: Perspectives of SSP Staff on Morale during the COVID-19 Pandemic, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Examination of COVID-19 Pandemic Impacts on Syringe Service Program Operations over Time, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Authors
- Susan Busch, PhD, Yale School of Public Health
- Impact of the Certified Community Behavioral Health Clinic Demonstration on Availability of Primary Care and Specialty Services in Community Mental Health Settings, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
- Offering Buprenorphine in Addiction Treatment Facilities: A Decomposition of Entry and Exit Dynamics, Contribution to Change, and the Role of the Comprehensive Addiction and Recovery Act, 2009-2020, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Medicaid ACO Contract Characteristics and the Availability of Substance Use Disorder Treatment: Evidence from a National Survey, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Jason M. Hockenberry, PhD, Yale School of Public Health
- Impact of the Certified Community Behavioral Health Clinic Demonstration on Availability of Primary Care and Specialty Services in Community Mental Health Settings, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Excluding Observation Stays from Pediatric Quality Measures: Disparities in Measuring Pediatric Preventable Hospitalizations, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Elbert Huang, MD, MPH, University of Chicago
- Chicago’s Community-Based Participatory Research Ecosystem: A Network Analysis, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Ali Jalali, PhD, MA, Weill Cornell Medicine
- County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Shashi Kapadia, MD, MS, Weill Cornell Medicine
- “a Lot of Us ‘essential’ Workers Could Replace the Word with ‘expendable'”: Perspectives of SSP Staff on Morale during the COVID-19 Pandemic, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Association between Diagnosis Setting and Treatment Initiation Among Medicare Patients with Hepatitis C, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Examination of COVID-19 Pandemic Impacts on Syringe Service Program Operations over Time, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Out-of-Pocket Costs and Initiation of HCV Treatment Among Medicare Beneficiaries Receiving Low-Income Subsidy, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Dhruv Khurana, PhD, MS, MA, David Geffen School of Medicine at UCLA
- The Effect of the Drug Medi-Cal Organized Delivery System on Substance Use Disorder Treatment Access: Evidence from California, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
- The Whole Person Health Score: A Patient-Focused Tool to Measure Nonmedical Determinants of Health, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
- Noa Krawczyk, PhD, NYU Grossman School of Medicine
- Narratives of Engaging in Emergency Services, Drug Treatment, and Harm Reduction Services Following Nonfatal Overdose in the COVID-19 Pandemic across States, 1:00 PM – 2:30 PM at 4C-4 (Level 4, Seattle Convention Center), Author
- Benjamin P. Linas, MD, MPH, Director, Population Data & Modeling Core, Boston Medical Center
- County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Tami Mark, PhD, MBA, RTI International
- Alcohol Use Disorder in Medicare: Health Consequences and Costs to Medicare, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- The Cost of Opioid Use Disorder-Related Conditions in Medicare, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
- The Effect of a Comprehensive Mental Health Crisis System on Suicide Hospitalizations, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Brandon Marshall, PhD, Brown University School of Public Health
- Association of Opioid Use Disorder Diagnosis with Use of Physical Therapy and Chiropractic Care Among Chronic Low Back Pain Patients: A Group-Based Trajectory Analysis, 1:00 PM – 2:30 PM at 4C-4 (Level 4, Seattle Convention Center), Author
- County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Jake R. Morgan, PhD, Investigator, Population Data & Modeling Core, Boston University School of Public Health
- Out-of-Pocket Spending and Healthcare Utilization Patterns Among Individuals Initiating Medications for Opioid Use Disorder: Findings from a Commercially-Insured National Cohort, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Sean M. Murphy, PhD, Co-director, Methodology Core, Director, Consultation Service, Weill Cornell Medicine
- County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Harold Pollack, PhD, MPP, University of Chicago School of Social Service Administration
- Evaluating the Impact of Therapeutic Communities in Prisons on Substance-Using Inmates, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Authors
- The Impact and Cost-Effectiveness of Combined Community and Jail-Based Take-Home Naloxone Distribution to Prevent Opioid Overdose Mortality, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
- The Way to a Man’s Heart (Disease): Exploring Connections between Male Adherence with Gendered Behavior and Cardiovascular Disease Risk, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Implementation Analysis of Chicago’s Multidisciplinary Crisis Response, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
- Daniel Polsky, PhD, Bloomberg Distinguished Professor at the Bloomberg, School of Public Health and the Carey School of Business, Johns Hopkins University
- Avoidable Hospitalizations in Medicare Advantage and Traditional Medicare, and the Role of Provider Networks, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Impact of Medicare Advantage Part B Step Therapy on Drug Utilization: Evidence from Macular Degeneration Drugs, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health
- Narratives of Engaging in Emergency Services, Drug Treatment, and Harm Reduction Services Following Nonfatal Overdose in the COVID-19 Pandemic across States, 1:00 PM – 2:30 PM at 4C-4 (Level 4, Seattle Convention Center), Author
- Bruce R. Schackman, PhD, MBA, Director, CHERISH, Co-director, Population Data & Modeling Core, Director, Administrative Core, Weill Cornell Medicine
- Examination of COVID-19 Pandemic Impacts on Syringe Service Program Operations over Time, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Authors
- Theresa Shireman, PhD, MS, Brown University School of Public Health
- Association of Opioid Use Disorder Diagnosis with Use of Physical Therapy and Chiropractic Care Among Chronic Low Back Pain Patients: A Group-Based Trajectory Analysis, 1:00 PM – 2:30 PM at 4C-4 (Level 4, Seattle Convention Center), Author
- Receipt of Gender-Affirming Surgeries Among Medicare Beneficiaries, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Authors
- Transgender Medicare Beneficiaries Emergency Room Utilization from 2011-2020, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Authors
- Revathy Suryanarayana, MSc, CHERISH pilot grantee 2022-2023, Cornell University
- Out-of-Pocket Costs and Initiation of HCV Treatment Among Medicare Beneficiaries Receiving Low-Income Subsidy, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
- Jeffery Talbert, PhD, University of Kentucky College of Medicine
- Rural Hospitals Post Lower Gross and Negotiated Prices for Common Services, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Cindy Parks Thomas, PhD, Brandeis University Heller School for Social Policy and Management
- Substance Use Treatment Services in Medicaid Managed Care Plans: Covered Services and Utilization Management Requirements, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Benjamin Ukert, PhD, Texas A & M University School of Public Health
- The Corporatization of Independent Hospitals, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
- Todd Wagner, PhD, Stanford University and VA Health, Economics Resource Center
- Differences across Race and Ethnicity in the Quality of Antidepressant Medication Management, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Authors
- Alexander Walley, MD, MSc, Investigator, Population Data & Modeling Core, Boston Medical Center
- County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Xiao Zang, PhD, University of Minnesota
- County-Level Proportion of Independent Vs. Chain Pharmacies and Naloxone Claims in the United States, 2:45 PM – 4:00 PM at Hall 4AB (Level 4, Seattle Convention Center), Author
- Gary A. Zarkin, PhD, MA, RTI International
- The Effect of a Comprehensive Mental Health Crisis System on Suicide Hospitalizations, 8:30 AM – 9:45 AM at Hall 4AB (Level 4, Seattle Convention Center), Presenting Author
Tuesday, June 27, 2023
- Kevin Callison, PhD, Tulane University School of Public Health & Tropical Medicine
- Market-Level Spillover Effects of the Medicare Shared Savings Program: Evidence from Movers, 10:30 AM – 12:00 PM at Ballroom 6A (Level 6, Seattle Convention Center), Authors
- Daniel Hartung, PharmD, MPH, Oregon State University
- Effect of Integration of Prescription Drug Monitoring Program Data in the Electronic Health Record, 8:30 AM – 10:00 AM at 4C-1 (Level 4, Seattle Convention Center), Presenting Author